Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain.
Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.
Cannabidiol, neuroprotection and neuropsychiatric disorders.
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders.
Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study.
COX-2 and PPAR-γ confer cannabidiol-induced apoptosis of human lung cancer cells.
Cannabidiol inhibits growth and induces programmed cell death in kaposi sarcoma-associated herpesvirus-infected endothelium.
A comparative study on cannabidiol-induced apoptosis in murine thymocytes and EL-4 thymoma cells.
Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer.